Sign in

Merck & Co., Inc.

MRK

Share price not shown yet: live market data is not connected. Everything below comes from MRK’s own SEC filings.

View options chain →

Fundamentals

SEC filings

Ratios that need a share price (P/E, PEG, P/S, dividend yield) are not shown yet, because live market data is not connected. Everything below comes from filed financials.

Rule of 40
29%
rev growth + FCF margin
Revenue growth
+4.6%
TTM vs prior TTM
FCF margin
24.1%
ROE (TTM)
7.0%
TTM NI ÷ avg equity
Net debt
$46.8B
total debt − cash & ST inv.
Dilution (YoY)
-1.2%
negative = buybacks
SBC / revenue
1.3%
TTM revenue
$66.6B

Revenue

$0B$5B$10B$15BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$17B

EPS (diluted)

$-2.00$-1.00$0.00$1.00$2.00Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$-0.54

Gross

66%68%70%72%74%76%78%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’2674%

Net income

-$6B-$4B-$2B$0B$2B$4B$6BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26-$1B

Net margin

-40%-20%0%20%40%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26-8%

Free cash flow vs. stock-based comp

FCFSBC
$0B$2B$4B$6B$8BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$4B

Operating cash flow vs. capex

OCFCapex
$0B$2B$4B$6B$8B$10BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$5B

R&D vs. SG&A

R&DSG&A
$0B$5B$10BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$10B

Insider activity

SEC Form 4
Reading Form 4 filings from SEC EDGAR…